Related Experiment Videos
Plasma Albumin Changes During Admission for Bloodstream Infection as Prognostic Predictors After Discharge-A
Kim Oren Gradel1,2, Ram Benny Dessau3,4, Jens Kjølseth Møller4,5
1Center for Clinical Epidemiology, Odense University Hospital, 5000 Odense, Denmark.
Journal of Clinical Medicine
|June 12, 2026
Summary
Low plasma albumin levels during bloodstream infection predict higher mortality, especially within 90 days. Changes in plasma albumin also strongly predict survival outcomes.
Area of Science:
- Clinical Medicine
- Biochemistry
- Epidemiology
Background:
- Plasma albumin (PA) levels can rapidly decline due to increased vascular loss, often associated with inflammatory conditions.
- A half-life of 18-20 days for PA means that changes in its levels can quickly reflect acute physiological events.
Purpose of the Study:
- To investigate the predictive value of plasma albumin (PA) levels and their changes on mortality in patients with bloodstream infection (BSI).
- To assess the impact of PA dynamics on mortality prediction models using Area Under the Receiver Operating Characteristic Curves (AUROCs).
Main Methods:
- A cohort of 11,562 adult patients with first-time BSI was analyzed, with at least two PA specimens during hospitalization.
- Cox regression models were used to evaluate PA levels (first, last, and changes) as predictors of mortality at various time points (1-30, 31-90, 91-365, >365 days).
- AUROCs were calculated to quantify the improvement in mortality prediction by incorporating PA dynamics into baseline models.
Main Results:
- The last PA specimen level and the change in PA levels between the first and last specimens were significant mortality predictors.
- Lower PA levels (<25 g/L) were associated with higher mortality (HR 3.69 for 1-30 days), while higher levels (≥35 g/L) were associated with lower mortality (HR 0.31).
- Incorporating PA changes improved the AUROCs for 1-30 day mortality from 0.72 to 0.79 and for 31-90 day mortality from 0.73 to 0.76.
Conclusions:
- The last recorded plasma albumin level during bloodstream infection admission is a potent predictor of mortality, particularly within the first 90 days.
- Improved mortality prediction was observed in younger, non-comorbid patients, and those with more dynamic changes in PA levels.
- These findings support the role of hypoalbuminemia primarily as a marker of acute inflammatory events.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Composition of Blood Plasma
Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins, binding to...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...